{
  "generated": "2025-10-23T09:24:46.134704+00:00",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "source_evidence": "entries/safety/caffeine-ren-caff-dose/renal_safety/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "REN-CAFF-DOSE_01",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_hemodynamics",
      "population": "Adults with renal hemodynamics concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/ren-caff-dose-01",
      "url": "https://doi.org/10.1234/ren-caff-dose-01",
      "citation": "REN-CAFF-DOSE_01 (2016); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal hemodynamics concerns; Outcome: renal_hemodynamics; DOI: 10.1234/ren-caff-dose-01; Adverse Events: Transient headache."
    },
    {
      "study_id": "REN-CAFF-DOSE_02",
      "year": 2017,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_hemodynamics",
      "population": "Adults with renal hemodynamics concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/ren-caff-dose-02",
      "url": "https://doi.org/10.1234/ren-caff-dose-02",
      "citation": "REN-CAFF-DOSE_02 (2017); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal hemodynamics concerns; Outcome: renal_hemodynamics; DOI: 10.1234/ren-caff-dose-02; Adverse Events: None reported."
    },
    {
      "study_id": "REN-CAFF-DOSE_03",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "renal_safety_journal",
      "outcome": "renal_hemodynamics",
      "population": "Adults with renal hemodynamics concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/ren-caff-dose-03",
      "url": "https://doi.org/10.1234/ren-caff-dose-03",
      "citation": "REN-CAFF-DOSE_03 (2018); Journal: renal_safety_journal; Design: randomized controlled trial; Population: Adults with renal hemodynamics concerns; Outcome: renal_hemodynamics; DOI: 10.1234/ren-caff-dose-03; Adverse Events: Mild GI discomfort."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/ren-caff-dose-01",
      "study_ids": [
        "REN-CAFF-DOSE_01"
      ],
      "primary_study_id": "REN-CAFF-DOSE_01",
      "url": "https://doi.org/10.1234/ren-caff-dose-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ren-caff-dose-02",
      "study_ids": [
        "REN-CAFF-DOSE_02"
      ],
      "primary_study_id": "REN-CAFF-DOSE_02",
      "url": "https://doi.org/10.1234/ren-caff-dose-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ren-caff-dose-03",
      "study_ids": [
        "REN-CAFF-DOSE_03"
      ],
      "primary_study_id": "REN-CAFF-DOSE_03",
      "url": "https://doi.org/10.1234/ren-caff-dose-03"
    }
  ],
  "manifest_hash": "sha256:2b7c7fe27955dc7efb0afff97628ed0ca48bcb9cd4cee8e208201f51c7f7052a"
}
